The “Prefilled Syringe Fill / Finish Service Providers, 2020-2030
Key Inclusions
§ A detailed review of the overall landscape of companiesoffering contract fill / finish services for prefilled syringes, along withanalyses based on a number of relevant parameters, such as year ofestablishment, company size, scale of operation (preclinical, clinical andcommercial), location of the headquarters, location of fill / finishfacilities, type of drug molecule (small molecule and biologic), syringe barrelmaterial (glass and plastic), syringe fill volume and additional servicesoffered (drug formulation, regulatory support, labelling and packaging,terminal sterilization, storage and logistics). In addition, the chapterincludes details on prefilled syringe fill / finish installed capacity of theservice providers.
§ Tabulated profiles of key players (shortlisted based on aproprietary criterion) across key geographies, such as North America, Europeand Asia-Pacific. Each profile provides an overview of the company, informationon its overall service portfolio, fill / finish facilities, financialperformance (if available), and details on recent developments as well as aninformed future outlook.
§ An analysis of the recent developments (since 2015)pertaining to contract fill / finish services, based on various parameters,such as year of development, type of activity / development (collaboration andexpansions), scale of operation of the project, location of expanded facility,type of drug molecule involved and additional services offered.
§ An estimate of the global, contract fill / finish capacityof prefilled syringes, by taking into consideration the capacities of variousfill / finish service providers (as available on respective company websites),collected via secondary and primary research. The study examines thedistribution of number of prefilled syringe units and volume of drug filled,based on the company size of manufacturer (small-sized, mid-sized and large),scale of operation (preclinical / clinical and commercial), location ofheadquarters and fill / finish facilities (North America, Europe andAsia-Pacific) and type of drug molecule (small molecule and biologics).
§ An informed estimate of the annual demand for fill / finishof prefilled syringes (in number of units), taking into account the marketeddrugs available in prefilled syringes and other relevant parameters, such astarget patient population, dosing frequency and dose strength. The study providesthe distribution of the annual demand, based on the geography (North America(US), Europe (UK, France, Italy, Spain, Germany and rest of Europe), LatinAmerica (Brazil, Mexico, Argentina and rest of Latin America), Asia-Pacific(Japan, China, India, South Korea and rest of Asia-Pacific), and the MiddleEast and Africa (Saudi Arabia, UAE, Africa and rest of the Middle East)), typeof drug molecule (small molecule and biologics), therapeutic area (blooddisorders, infectious diseases, metabolic disorders, oncological disorders andothers), syringe barrel material (glass and plastic) and number of barrelchambers (single chamber and dual chamber).
§ A detailed demand and supply assessment of geographies,based on a number of parameters, such as the number of prefilled syringecombination product developers, number of prefilled syringe manufacturers,number of prefilled syringe fill / finish service providers, number ofprefilled syringe fill / finish facilities, capacity and demand for prefilledsyringes in that particular geographical region.
§ An analysis presenting potential strategic partners(primarily drug developers) for prefilled syringe fill / finish serviceproviders, based on different parameters, such as developer strength, pipelinestrength, type of drug molecule, target therapeutic area and location of theheadquarters of the company.
§ A discussion on the potential growth areas, such as growinginjectable drugs pipeline, increasing popularity of prefilled syringes, rise inpreference for outsourcing of fill /finish operations, technological advancements in aseptic fill / finishprocesses, and growing opportunities in the Asia-Pacific region.
§ A review of the landscape of prefilled syringemanufacturers, featuring a list of key prefilled syringes and theirmanufacturers, analyzed based on a number of relevant parameters, such assyringe barrel material (glass and plastic), number of barrel chambers (singlechamber and dual chamber), type of needle system (fixed needle system, luerlock and luer cone) barrel volume, year of establishment and location of theheadquarters of manufacturers.
The report also features thelikely distribution of the current and forecasted opportunity across importantmarket segments, mentioned below:
- Scale of Operation
§ Preclinical /Clinical
§ Commercial
- Type of drug molecule
§ Biologic
§ Small Molecule
- Target therapeutic area
§ Blood disorders
§ Infectious diseases
§ Metabolic disorders
§ Oncological disorders
§ Neurologicaldisorders
§ Autoimmune disorders
§ Others
- Syringe barrel material
§ Glass
§ Plastic
- Number of barrel chambers
§ Single chamber
§ Dual chamber
- Key Geographical Regions
§ North America
§ Europe
§ Latin America
§ Asia-Pacific
§ Middle East andAfrica
To request samplepages, please visit this https://www.rootsanalysis.com/reports/301/request-sample.html
Key QuestionsAnswered
§ Who are the keyplayers offering fill / finish in prefilled syringes, across the globe?
§ Whatis the current, installed capacity for fill / finish in prefilled syringes?
§ What is the annual,demand for prefilled syringes, at both clinical and commercial scales?
§ Whatare the key geographical hubs of fill / finish services for prefilled syringes?
§ Whatare the key growth drivers within this domain?
§ How is the currentand future market opportunity likely to be distributed across key marketsegments?
You may also be interested in the followingtitles:
1. PrefilledSyringes Market (5th Edition), 2020-2030
2. BiologicsFill / Finish Services Market, 2019-2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
